The Direct-to-Consumer (DTC) gene testing industry has generated a lot of press over the last five or six years. But the business plan has always seemed rather on the South Park side of logical. Now two of the major players in the gene testing industry — 23andMe and Family Tree DNA — along with upstart GenePeeks are launching new ventures that could remake the direct-to-consumer (DTC) market.
- “DNA DTC: The Return of Direct to Consumer Whole Genome Sequencing,” Genomics Law Report
- “Virtual Children, Genome Sequencing for Everyone, and Forget Genetic Privacy,” Reason.com
View the original article here: New Business Plans for the Direct-to-Consumer Gene Testing Industry?